3.14 COVID-19 with Dr. John Ioannidis & Trial Eligibility with Dr. Mary-Elizabeth Percival

This week we have a two-hour-long, far-ranging interview with Dr. John Ioannidis of Stanford University on, broadly, meta-research and COVID-19 - including his recent controversies. We end the episode with an interview with Dr. Mary-Elizabeth Percival of the University of Washington on her new paper out now in Haematologica: "Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility".

High-Grade Myeloid Neoplasms: doi.org/10.3324/haematol.2020.254938

Back us on Patreon! www.patreon.com/plenarysession

Vinay Prasad
HemeOnc Doctor & Associate Professor
Host of Plenary Session Podcast
https://soundcloud.com/plenarysession
Twitter @vprasadmdmph